Stock Screener App

Frei -

Installieren

3.37

3.06% 0.10

after-market

Handel nachbörslich: 3.37

An 2 Therapeutics Inc (ANTX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der An 2 Therapeutics Inc-Aktie (ANTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	39.14% 10.04	7.216	11.54	8.598	14.01
Operating Income/Loss	39.14% -10.04	-7.216	-11.54	-8.598	-14.01
Income/Loss From Continuing Operations Before Tax	44.74% -9.353	-6.462	-10.65	-7.522	-12.75
Income/Loss From Continuing Operations After Tax	44.74% -9.353	-6.462	-10.65	-7.522	-12.75
Net Income/Loss	44.74% -9.353	-6.462	-10.65	-7.522	-12.75
Preferred Stock Dividends And Other Adjustments	-	-	-	0.001	-
Attributable To Noncontrolling Interest	-	-	-	-0.001	-
Basic Average Shares	0.34% 30.28	30.17	30.05	0.0184	29.84
Diluted Average Shares	0.34% 30.28	30.17	30.05	0.0184	29.84
Basic Earnings Per Share	47.62% -0.31	-0.21	-0.35	-0.25	-0.43
Diluted Earnings Per Share	47.62% -0.31	-0.21	-0.35	-0.25	-0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	0.001	-

MRNA

$48.77

0.87%

ROIV

$27.88

1.59%

RPRX

$47.32

2.57%

BNTX

$91.28

0.11%

ONC

$302.49

2.67%

INSM

$163.81

0.85%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters